Preceptorship program

08:30 – 09:00 Registration & Welcome 

09:00 – 09:15 Presentation of the preceptorship by the chairs and hosts

09:15 – 10:15 Session 1

  • Molecular Basis of thalassemia and genetic modifiers
  • Pathological erythropoiesis and BM niche (SCD and thalassemia related)

10:015 – 10:30 Coffee break

10:30 – 11:30  Session 2

  • Pathophysiology of thalassemia linked to organ complications
  • Pathophysiology of SCD linked to organ complications

11:30 – 12:30 Session 3

  • NTDT with a focus on alpha thalassemia
  • Management of NTDT and phenoconversion

12:30 – 13:30 Lunch break

13:30 – 15:30 Session 4

  • Iron Chelation
  • Transfusion strategies in hemoglobinopathies
  • Alloimmunization in Thalassemia and SCD
  • Pediatric care in hemoglobinopathies

15:30 – 15:45 Coffee break

15:45 – 17:15 Session 5

  • How do you manage Thrombotic Complications in hemoglobinopathies
  • How do you manage Cardiac Complications in hemoglobinopathies
  • How do you manage liver disease in Patients with hemoglobinopathies

17:15 – 18:00 Q&A Clossing session

19:30 – 21:30 Group dinner

08:30 – 10:00 Clinical case sharing part 1

10:00 – 11:00 Clinical cases from all groups

11:00 – 11:15 Coffee break

11:15 – 12:15 Session 6

  • The contribution of MRI and liver elastography in Hemoglobinopathies
  • Brain imaging

12:15 – 13:15 Lunch break

13:15 – 14:45 Session 7

  • Thalassemia and SCD Screening and counseling Strategies
  • NGS in the diagnosis of hemoglobin, PGD (preimplantation diagnosis) and NIPT (non-invasive prenatal testing)
  • Pregnancy in Thalassemia and SCD

14:45 – 15:45 Session 8

  • Cancer risk / Age‑related complications
  • Extramedullary Hemopoiesis Diagnosis and Management

15:45 – 16:00 Coffee break

16:00 – 17:30 Clinical case sharing part 2

17:30 – 18:00 Q&A session and closing of Day 2

08:30 – 10:00 Hands-on workshop “In the lab” (transfusion) and clinical tour

  • Group 1: First-level diagnostic tests for carrier screening and molecular Testing, PND and Genetic Counsellings
  • Group 2: Patient therapeutic education

(group rotation)

10:00 – 10:15 Coffee break

10:15 – 11:15 Session 9

  • New approved Drugs for hemoglobinopathies
  • New approved Drugs for Thalassemia
  • New approved Drugs for SCD

11:15 – 12:15 Session 10

  • HSCT
  • Gene Therapy and Gene Editing

12:15 – 12:45 Faculty case sharing

12:45 – 13:00 Closing

13:00 – 13:30 Farewell lunch

Share